VEGFB and type 2 diabetes mellitus: Hagberg et al., proposed that VEGF-B induces fatty acid transport across the endothelium in brown adipose tissue, skeletal muscle, heart, and that blockade of VEGF-B may be a novel treatment for type 2 diabetes [22].